Together with GSK Oncology Patient Support Services

GSK offers the Together with GSK Oncology program for patients who are prescribed a GSK oncology drug (Table).

Together with GSK Oncology

GSK Co-pay Assistance Program

Eligible patients with commercial insurance may receive assistance with their out-of-pocket expenses for Zejula, Blenrep, or Jemperli, including up to $100 per administration for intravenous drugs, for a total annual limit of $26,000. Patients may be eligible if they:

• Have a commercial medical or prescription insurance plan
• Are uninsured
• Reside in the United States, including the District of Columbia, Puerto Rico, or the US Virgin Islands
• Are not eligible for or enrolled in a government-funded program
• Are ≥18 years of age.

Patient Assistance Program

Uninsured patients who meet eligibility requirements may access medication free of charge through GSK’s Patient Assistance Program.
Patients may be eligible for this program if they:

• Are uninsured
• Have Medicare and meet other program requirements
• Live in the United States, Puerto Rico, or the US Virgin Islands
• Meet financial income eligibility criteria
• Are ≥18 years of age.

Ophthalmology Support Services

The Ophthalmology Support Services program helps eligible, enrolled patients who are taking Blenrep locate an eye care professional, schedule an eye care appointment, and provide reminders for scheduled eye care appointments. To learn more, call Together with GSK Oncology at 844-447-5662.

Zejula Quick Start and Bridge Programs

For patients experiencing delay in coverage at first dispense of Zejula (Quick Start) or coverage interruptions while already on treatment (Bridge), download and fill out the enrollment form, then fax to Together with GSK Oncology at 800-645-9043 to check for eligibility. Click here to access the form.

TABLE GSK Oncology Drugs